Top News
Incidence of Leukemias But Not All Cancers Increasing as US Baby Boomers Reach 65
Risk of Cancer in Individuals With Lynch Syndrome Can Vary With Age, Gender, and MMR Gene Alteration
Statins Linked to Lower Risk of Liver Cancer in Patients With Hepatitis B/C
Androgen Therapy in Lower-Risk Myelodysplastic Syndrome Can Result in Hematologic Improvement
Outcomes With a 12-Week Schedule of Zoledronic Acid for Treatment of Bone Metastasis
Delayed RC for Histologic Variant Urothelial Bladder Cancer Ups Death Risk
USPSTF Recommends Genetic Counseling for High BRCA Risk
Patient Preferences Explored in Multiple Myeloma Treatment
PARP Inhibitor Combination Shows Activity in Small Cell Lung Cancer
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
Tapping Into the Therapeutic Expertise of High-Volume Cancer Centers
Researchers examine how patient outcomes could be affected if patients were to receive systemic drug treatment at dedicated cancer centers versus at community health systems. -
MGUS: Risk of Progression to Multiple Myeloma Can Change Over Time
A risk signature is not constant in a given patient over time—it is subject to change depending on a variety of factors. -
Previously Hidden FDA Data Reveal a Multitude of Adverse Events Linked to Breast Implants
Why were adverse events reported through an alternative reporting channel as opposed to a more transparent means? -
Personalized Cancer Vaccine NEO-PV-01 Shows Promise in Three Types of Advanced Cancer
Early results from a clinical trial of personalized cancer vaccine NEO-PV-01 in 3 types of advanced cancer have shown promise and no significant toxicity issues. -
Looking at Survival Differently in Patients With Metastatic Kidney Cancer
Conditional survival may more accurately assess prognosis than traditional survival for patients with metastatic kidney cancer, but the metric is not without its caveats. -
Female Childhood Cancer Survivors Are at Increased Risk for Breast Cancer Due to Anthracycline Treatment
Survivors of childhood cancers who were treated with anthracyclines are at increased risk for developing breast cancer.
More Features
ACP Releases Policy Statement on DOI, COI Management for Clinical Guideline Development
The American College of Physicians endorses the necessity of a comprehensive process for disclosure of potential conflicts of interest to ensure the integrity of clinical guidelines and guidance statements.
Real-World Data in the Era of Precision Medicine for Lymphoid Malignancies
The use of real-world data shows promise in guiding the development of management strategies for lymphoid malignancies.
A Tool to Select Candidates for Allogeneic Hematopoietic Cell Transplant in CLL
As oncologists welcome new chronic lymphocytic leukemia treatments, one researcher creates a scoring system to make the case for transplants.
New Trial Attempts to Make Genetic Counseling and Testing More Accessible
The researchers wrote that “genetic counseling must be further explored to find an optimal balance of clinical quality with increased access and financial sustainability.”
T-Cell Cryopreservation for Use in Future Cancer Treatment: Hot or Hype?
Can healthy immune cells from a patient be frozen and used in the future to make adoptive cell therapies in the event of a cancer diagnosis?
